Agilent Technologies Inc (A)
139.45
+1.93
(+1.40%)
USD |
NYSE |
May 03, 16:00
139.51
+0.06
(+0.04%)
After-Hours: 20:00
Agilent Technologies Cash from Investing (Quarterly): -95.00M for Jan. 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -95.00M |
| October 31, 2023 | -40.00M |
| July 31, 2023 | -89.00M |
| April 30, 2023 | -77.00M |
| January 31, 2023 | -104.00M |
| October 31, 2022 | -110.00M |
| July 31, 2022 | -73.00M |
| April 30, 2022 | -76.00M |
| January 31, 2022 | -79.00M |
| October 31, 2021 | -59.00M |
| July 31, 2021 | -61.00M |
| April 30, 2021 | -587.00M |
| January 31, 2021 | -42.00M |
| October 31, 2020 | -27.00M |
| July 31, 2020 | -32.00M |
| April 30, 2020 | -53.00M |
| January 31, 2020 | -35.00M |
| October 31, 2019 | -1.193B |
| July 31, 2019 | -51.00M |
| April 30, 2019 | -56.00M |
| January 31, 2019 | -290.00M |
| October 31, 2018 | -114.00M |
| July 31, 2018 | -473.00M |
| April 30, 2018 | -51.00M |
| January 31, 2018 | -67.00M |
| Date | Value |
|---|---|
| October 31, 2017 | -59.00M |
| July 31, 2017 | -101.00M |
| April 30, 2017 | -43.00M |
| January 31, 2017 | -101.00M |
| October 31, 2016 | -78.00M |
| July 31, 2016 | -24.00M |
| April 30, 2016 | -108.00M |
| January 31, 2016 | -28.00M |
| October 31, 2015 | -275.00M |
| July 31, 2015 | -87.00M |
| April 30, 2015 | -7.00M |
| January 31, 2015 | -31.00M |
| October 31, 2014 | -58.00M |
| July 31, 2014 | -70.00M |
| April 30, 2014 | -55.00M |
| January 31, 2014 | -47.00M |
| October 31, 2013 | -51.00M |
| July 31, 2013 | -54.00M |
| April 30, 2013 | -71.00M |
| January 31, 2013 | -72.00M |
| October 31, 2012 | -92.00M |
| July 31, 2012 | -2.20B |
| April 30, 2012 | -56.00M |
| January 31, 2012 | -18.00M |
| October 31, 2011 | -48.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.193B
Minimum
Oct 2019
-27.00M
Maximum
Oct 2020
-151.74M
Average
-73.00M
Median
Jul 2022
Cash from Investing (Quarterly) Benchmarks
| Bio-Rad Laboratories Inc | 72.20M |
| Revvity Inc | -18.18M |
| Bruker Corp | -304.20M |
| Azenta Inc | 98.40M |
| Harvard Bioscience Inc | -1.061M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 485.00M |
| Cash from Financing (Quarterly) | -240.00M |
| Free Cash Flow | 1.649B |
| Free Cash Flow Per Share (Quarterly) | 1.344 |
| Free Cash Flow to Equity (Quarterly) | 575.00M |
| Free Cash Flow to Firm (Quarterly) | 398.45M |
| Free Cash Flow Yield | 4.00% |